COMMUNIQUÉS West-GlobeNewswire

Cytokinetics Announces Preclinical Data For Reldesemtiv Presented at the 2019 Annual Cure SMA Conference
28/06/2019
Two Studies Show Addition of Reldesemtiv to SMN-Directed Treatment Increases Muscle Force in Mouse Model of Spinal Muscular Atrophy SOUTH SAN FRANCISCO, Calif., June 28, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, [...]
T2 Biosystems Named One of the Fastest-Growing Companies in Massachusetts
28/06/2019
Company ranked #22 on the Boston Business Journal’s annual list of the fastest-growing public companies in Massachusetts LEXINGTON, Mass., June 28, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in [...]
Hemispherx Biopharma CFO Adam Pascale Announces Retirement
28/06/2019
OCALA, Fla., June 28, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) announced today that Adam Pascale is retiring from the position of Chief Financial Officer after nearly a quarter century [...]
Akorn Announces Launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%
28/06/2019
LAKE FOREST, Ill., June 28, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it has launched its first-to-market generic of Loteprednol [...]
FibroGen to Present Interim Phase 2 Data on Pamrevlumab in Subjects with Duchenne Muscular Dystrophy at the Parent Project Muscular Dystrophy 2019 Annual Conference
28/06/2019
SAN FRANCISCO, June 28, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), today announced that the company will present interim data on their open-label, single-arm Phase 2 trial evaluating pamrevlumab, a [...]
Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for moderate-to-severe atopic dermatitis in adolescents
28/06/2019
CHMP recommends approval of Dupixent ® (dupilumab) for moderate-to-severe atopic dermatitis in adolescents PARIS AND TARRYTOWN, NY – June 27, 2019 - The European Medicines Agency’s Committee for Medicinal Products for [...]
Sanofi : Le CHMP recommande l’approbation de Dupixent® (dupilumab) dans le traitement de la dermatite atopique modérée à sévère de l’adolescent
28/06/2019
Le CHMP recommande l’approbation de Dupixent ® (dupilumab) dans le traitement de la dermatite atopique modérée à sévère de l’adolescent Paris et Tarrytown (New York) – Le 27 juin 2019 - Le Comité des médicaments à usage [...]
Athenex Announces Strategic Global Initiatives to Expand Clinical Operations
28/06/2019
BUFFALO, N.Y., June 28, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
CHMP recommends EU approval of Roche’s Tecentriq in combination with Abraxane as an initial treatment for people with PD-L1-positive, metastatic triple-negative breast cancer
28/06/2019
Recommendation based on the results of IMpassion130 study in triple-negative breast cancer, an aggressive type of breast cancer with high unmet medical need First positive Phase III cancer immunotherapy study for people [...]
La Jolla Pharmaceutical Company Receives Positive CHMP Opinion for GIAPREZA™ (angiotensin II) for the Treatment of Refractory Hypotension in Adults with Septic or Other Distributive Shock
28/06/2019
SAN DIEGO, June 28, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
Cerecor Added to Russell 3000® Index
28/06/2019
ROCKVILLE, Md., June 28, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in [...]
Sorrento Therapeutics Announces Proposed Public Offering of Common Stock and Warrants
28/06/2019
SAN DIEGO, June 28, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a clinical stage, antibody-centric biopharmaceutical company developing new therapies to turn malignant cancers into [...]
Chi-Med Announces Pricing of Upsized U.S. Public Secondary Offering of American Depositary Shares
28/06/2019
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION LONDON, June 28, 2019 (GLOBE [...]
Managers' transactions
28/06/2019
Company Announcement No. 10/2019 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384 Attachment No 10 [...]
Immunicum AB (publ) Announces New Issuance Date for Interim Report April – June 2019 and Corporate Update Event
28/06/2019
Press Release 28 June 2019 Immunicum AB (publ) Announces New Issuance Date for Interim Report April – June 2019 and Corporate Update Event Interim Report April – June 2019 to be published on Tuesday, August 20, 2019 [...]
Change in number of shares and votes in Saniona AB (publ)
28/06/2019
PRESS RELEASE June 28, 2019 Change in number of shares and votes in Saniona AB (publ) During June, the registered number of shares and votes in Saniona AB (publ) (“Saniona”) has increased due to conversion of [...]
Curetis Reports Results of the Annual General Meeting Held on June 27, 2019
28/06/2019
- All proposed AGM resolutions approved by shareholders Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, June 28, 2019, 08:00 am CEST / 02:00 am EDT - Curetis N.V. (the " Company " and [...]
Valneva Shareholders Approve all Resolutions Recommended by the Management Board at the Annual General Meeting
28/06/2019
Valneva Shareholders Approve all Resolutions Recommended by the Management Board at the Annual General Meeting Saint Herblain (France), June 28, 2019 – Valneva SE (“Valneva” or “the Company”), a biotech company [...]
Les actionnaires de Valneva approuvent toutes les résolutions recommandées par le directoire à l’Assemblée Générale du Groupe
28/06/2019
Les actionnaires de Valneva approuvent toutes les résolutions recommandées par le directoire à l’Assemblée Générale du Groupe Saint Herblain (France), 28 juin, 2019 – Valneva SE (“Valneva” ou “le Groupe”), société de [...]

Pages